Smith+Nephew reports Q1 2026 growth driven by innovation, despite regional variations

nl.investing.com (Dutch)

Smith+Nephew reported Q1 2026 results meeting expectations, but showing significant regional and product line variations. The medical device maker's revenue grew 3.1% to $1,501 million, driven by innovation and new product launches contributing over half of the growth. The company maintained its full-year guidance, expecting around 6% underlying revenue growth, while facing challenges in certain segments and markets.


With a significance score of 0.9, this news ranks in the top 80% of today's 33912 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Smith+Nephew reports Q1 2026 growth driven by innovation, despite regional variations | News Minimalist